Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region - Global Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNITS CONSIDERED
• 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ELASTOMERIC INFUSION PUMPS MARKET
• 3.2 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE AND COUNTRY
• 3.3 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE
• 3.4 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION
• 3.5 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY
• 3.6 ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising prevalence of chronic diseases
    • 4.2.1.2 Growing shift to ambulatory and home-based care
    • 4.2.1.3 Disposable and portable design
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Rising risks of incorrect drug delivery and performance variability
    • 4.2.2.2 Regulatory recalls on elastomeric pump reliability
    • 4.2.2.3 Stringent regulatory approvals and compliance requirements
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Rising healthcare advancements in emerging economies
    • 4.2.3.2 Specialization for high-viscosity drugs and biologics
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Intense competition with electronic infusion technologies
    • 4.2.4.2 Maintaining precision and safety in scaled elastomeric pump production
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN ELASTOMERIC INFUSION PUMPS MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
  • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF SUPPLIERS
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC ANALYSIS
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECASTS
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE OF ELASTOMERIC INFUSION PUMPS, BY TYPE
  • 5.5.2 AVERAGE SELLING PRICE ANALYSIS, BY REGION
• 5.6 TRADE ANALYSIS
  • 5.6.1 EXPORT SCENARIO (HS CODE 901890)
  • 5.6.2 IMPORT SCENARIO (HS CODE 901890)
• 5.7 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.8.1 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.9 INVESTMENT AND FUNDING SCENARIO
• 5.10 CASE STUDY ANALYSIS
  • 5.10.1 MOBILITY ENHANCEMENT IN INFUSION THERAPY USING SUREFUSER+ PUMP
  • 5.10.2 COST-SAVING POTENTIAL OF ELASTOMERIC PUMPS IN POSTOPERATIVE PAIN THERAPY
  • 5.10.3 IMPROVED QUALITY OF LIFE IN CHEMOTHERAPY WITH SUREFUSER+ PUMP
• 5.11 IMPACT OF 2025 US TARIFF: ELASTOMERIC INFUSION PUMPS MARKET
  • 5.11.1 INTRODUCTION
  • 5.11.2 KEY TARIFF RATES
  • 5.11.3 PRICE IMPACT ANALYSIS
  • 5.11.4 IMPACT ON COUNTRIES/REGIONS
    • 5.11.4.1 US
    • 5.11.4.2 China
    • 5.11.4.3 Europe
    • 5.11.4.4 Brazil
  • 5.11.5 IMPACT ON END-USE INDUSTRIES

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 PRECISION FLOW CONTROL SYSTEMS AND MULTI-RATE DESIGNS
  • 6.1.2 ADVANCED MATERIALS FOR DRUG STABILITY
  • 6.1.3 ELASTOMERIC MEMBRANE FOR PRESSURE GENERATION
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 ANTIMICROBIAL AND BIOCOMPATIBLE MATERIALS
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 SMART CONNECTIVITY AND IOT INTEGRATION
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.4.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 6.4.2 MID-TERM (2027-2030) | EXPANSION & INTEGRATION
  • 6.4.3 LONG-TERM (2030-2035+) | MATURITY & AUTONOMOUS SYSTEMS
• 6.5 PATENT ANALYSIS
  • 6.5.1 INTRODUCTION
  • 6.5.2 METHODOLOGY
  • 6.5.3 ELASTOMERIC INFUSION PUMPS MARKET, PATENT ANALYSIS, 2015-2024
• 6.6 FUTURE APPLICATIONS
  • 6.6.1 INTEGRATION WITH DIGITAL HEALTH FOR REMOTE MONITORING
  • 6.6.2 EXPANSION INTO VETERINARY AMBULATORY CARE
  • 6.6.3 DELIVERY OF ADVANCED THERAPEUTICS LIKE BIOLOGICS AND GENE THERAPY
  • 6.6.4 BIOLUMINESCENT INDICATOR FILMS
• 6.7 IMPACT OF AI/GEN AI ON ELASTOMERIC INFUSION PUMPS MARKET
  • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
  • 6.7.2 BEST PRACTICES IN ELASTOMERIC INFUSION PUMP PROCESSING
  • 6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ELASTOMERIC INFUSION PUMPS MARKET
  • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN ELASTOMERIC INFUSION PUMPS MARKET
• 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
  • 6.8.1 UNIVERSITY OF MICHIGAN DEPLOYS DOSI-FUSER ELASTOMERIC INFUSION SYSTEM FOR HOME CHEMOTHERAPY
  • 6.8.2 PEDIATRIC HOME CHEMOTHERAPY (INTACT@HOME, CANADA)
  • 6.8.3 PALLIATIVE CARE AND END-OF-LIFE SYMPTOM MANAGEMENT (SOUTHERN ONTARIO, CANADA)

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
• 7.2 SUSTAINABILITY INITIATIVES
  • 7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF ELASTOMERIC INFUSION PUMPS
    • 7.2.1.1 Carbon impact reduction
    • 7.2.1.2 Eco-applications
• 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
• 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY
  • 8.5.1 REVENUE POTENTIAL
  • 8.5.2 COST DYNAMICS
  • 8.5.3 MARGIN OPPORTUNITIES, BY APPLICATION

9 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE

• 9.1 INTRODUCTION
• 9.2 CONTINUOUS RATE
  • 9.2.1 DEMAND FOR PRECISE, PORTABLE, AND POWER-FREE DRUG DELIVERY IN OUTPATIENT CARE TO DRIVE MARKET
• 9.3 VARIABLE RATE
  • 9.3.1 RISING NEED FOR PERSONALIZED AND ADJUSTABLE DRUG DELIVERY IN AMBULATORY CARE TO DRIVE DEMAND

10 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 CHEMOTHERAPY
  • 10.2.1 RISING CANCER INCIDENCE AND SHIFT TOWARD OUTPATIENT CHEMOTHERAPY DRIVING ADOPTION
• 10.3 PAIN MANAGEMENT
  • 10.3.1 RISING PREVALENCE OF CHRONIC PAIN AND DEMAND FOR OUTPATIENT ANALGESIC DELIVERY TO SUPPORT MARKET GROWTH
• 10.4 ANTIBIOTICS
  • 10.4.1 GROWTH OF OUTPATIENT ANTIBIOTIC THERAPY AND HOME-BASED CARE DRIVING ADOPTION
• 10.5 OTHER APPLICATIONS

11 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY

• 11.1 INTRODUCTION
• 11.2 HOSPITALS
  • 11.2.1 NEED FOR ENHANCING PATIENT CARE AND OPERATIONAL EFFICIENCY TO DRIVE MARKET
• 11.3 AMBULATORY SURGICAL CENTERS (ASCS)
  • 11.3.1 OFFERS OPTIMIZED OUTPATIENT SURGICAL CARE WITH EFFICIENT DRUG DELIVERY
• 11.4 HOMECARE SETTINGS
  • 11.4.1 INCREASING DEMAND FOR SAFE AND INDEPENDENT HOME- BASED CARE TO DRIVE MARKET
• 11.5 OTHER END-USE INDUSTRIES

12 ELASTOMERIC INFUSION PUMPS MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 US
    • 12.2.1.1 Rising cancer prevalence driving demand for continuous infusion therapies
  • 12.2.2 CANADA
    • 12.2.2.1 Aging population and increasing cancer cases propelling growth
  • 12.2.3 MEXICO
    • 12.2.3.1 Government health initiatives and rising chronic disease burden to boost demand
• 12.3 EUROPE
  • 12.3.1 GERMANY
    • 12.3.1.1 Strong healthcare infrastructure and growing preference for home-based care to drive demand
  • 12.3.2 FRANCE
    • 12.3.2.1 Rising oncology cases and preference for outpatient care to boost market growth
  • 12.3.3 UK
    • 12.3.3.1 Strong healthcare infrastructure and rising cancer burden driving demand
  • 12.3.4 ITALY
    • 12.3.4.1 Increasing chronic pain burden driving adoption
  • 12.3.5 SPAIN
    • 12.3.5.1 Rising cancer incidence and aging population fueling demand
  • 12.3.6 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 CHINA
    • 12.4.1.1 Growing hospital infrastructure and rising outpatient care fueling adoption
  • 12.4.2 JAPAN
    • 12.4.2.1 Growing aging population to support market growth
  • 12.4.3 INDIA
    • 12.4.3.1 Expanding cancer care infrastructure and home-based treatment driving adoption
  • 12.4.4 SOUTH KOREA
    • 12.4.4.1 Rising healthcare needs and technological integration to accelerate market growth
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Increased healthcare spending driving market growth
  • 12.4.6 REST OF ASIA PACIFIC
• 12.5 SOUTH AMERICA
  • 12.5.1 BRAZIL
    • 12.5.1.1 Government healthcare programs and expanding chronic care infrastructure propelling adoption
  • 12.5.2 ARGENTINA
    • 12.5.2.1 Expanding healthcare infrastructure and chronic disease management boosting adoption
  • 12.5.3 REST OF SOUTH AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 GCC COUNTRIES
    • 12.6.1.1 Saudi Arabia
      • 12.6.1.1.1 Healthcare transformation and localization initiatives under Vision 2030 to accelerate demand
    • 12.6.1.2 UAE
      • 12.6.1.2.1 Expanding healthcare infrastructure fueling adoption of elastomeric infusion pumps
    • 12.6.1.3 Rest of GCC Countries
  • 12.6.2 SOUTH AFRICA
    • 12.6.2.1 National health insurance implementation and chronic care initiatives to fuel growth
  • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYERS' STRATEGIES
• 13.3 MARKET SHARE ANALYSIS
• 13.4 REVENUE ANALYSIS
• 13.5 COMPANY VALUATION AND FINANCIAL METRICS
• 13.6 PRODUCT/BRAND COMPARISON
• 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 13.7.1 STARS
  • 13.7.2 EMERGING LEADERS
  • 13.7.3 PERVASIVE PLAYERS
  • 13.7.4 PARTICIPANTS
  • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 13.7.5.1 Company footprint
    • 13.7.5.2 Regional footprint
    • 13.7.5.3 Type footprint
    • 13.7.5.4 Application footprint
    • 13.7.5.5 End-use industry footprint
• 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 13.8.1 PROGRESSIVE COMPANIES
  • 13.8.2 RESPONSIVE COMPANIES
  • 13.8.3 DYNAMIC COMPANIES
  • 13.8.4 STARTING BLOCKS
  • 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 13.8.5.1 Detailed list of key startups/SMEs
    • 13.8.5.2 Competitive benchmarking of key startups/SMEs
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 DEALS
  • 13.9.2 EXPANSIONS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 BAXTER
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products/Solutions/Services offered
    • 14.1.1.3 MnM view
      • 14.1.1.3.1 Key strengths
      • 14.1.1.3.2 Strategic choices
      • 14.1.1.3.3 Weaknesses and competitive threats
  • 14.1.2 B. BRAUN SE
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products/Solutions/Services offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Deals
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Key strengths
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses and competitive threats
  • 14.1.3 NIPRO
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products/Solutions/Services offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Deals
      • 14.1.3.3.2 Expansions
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Key strengths
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses and competitive threats
  • 14.1.4 AVNS
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products/Solutions/Services offered
    • 14.1.4.3 MnM view
      • 14.1.4.3.1 Key strengths
      • 14.1.4.3.2 Strategic choices
      • 14.1.4.3.3 Weaknesses and competitive threats
  • 14.1.5 VYGON
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products/Solutions/Services offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Deals
      • 14.1.5.3.2 Expansions
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Key strengths
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses and competitive threats
  • 14.1.6 WOOYOUNG MEDICAL CO., LTD.
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products/Solutions/Services offered
    • 14.1.6.3 MnM view
  • 14.1.7 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products/Solutions/Services offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Deals
    • 14.1.7.4 MnM view
  • 14.1.8 AMBU A/S
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products/Solutions/Services offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Expansions
    • 14.1.8.4 MnM view
  • 14.1.9 PALEX
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products/Solutions/Services offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Deals
    • 14.1.9.4 MnM view
  • 14.1.10 DAIKEN MEDICAL CO., LTD.
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products/Solutions/Services offered
    • 14.1.10.3 MnM view
• 14.2 OTHER PLAYERS
  • 14.2.1 PROMECON GMBH
  • 14.2.2 S&S MED
  • 14.2.3 EPIC MEDICAL
  • 14.2.4 MULTIMEDICAL S.R.L.
  • 14.2.5 TECNOLINE S.P.A.
  • 14.2.6 ZHEJIANG FERT MEDICAL DEVICE CO., LTD.
  • 14.2.7 ACE MEDICAL
  • 14.2.8 GAMASTECH SRL
  • 14.2.9 FIRST MEDICAL SOURCE
  • 14.2.10 DELTAMED
  • 14.2.11 VIKYMED ITALIA SRL
  • 14.2.12 CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.
  • 14.2.13 MAIS INDIA
  • 14.2.14 NARANG MEDICAL LIMITED
  • 14.2.15 ZEBRA MEDICAL

15 RESEARCH METHODOLOGY

• 15.1 RESEARCH DATA
  • 15.1.1 SECONDARY DATA
    • 15.1.1.1 Key data from secondary sources
  • 15.1.2 PRIMARY DATA
    • 15.1.2.1 Key data from primary sources
    • 15.1.2.2 Key industry insights
• 15.2 MARKET SIZE ESTIMATION
• 15.3 BASE NUMBER CALCULATION
  • 15.3.1 DEMAND-SIDE APPROACH
  • 15.3.2 SUPPLY-SIDE APPROACH
• 15.4 MARKET FORECAST APPROACH
  • 15.4.1 SUPPLY SIDE
  • 15.4.2 DEMAND SIDE
• 15.5 DATA TRIANGULATION
• 15.6 FACTOR ANALYSIS
• 15.7 RESEARCH ASSUMPTIONS
• 15.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT

16 ADJACENT & RELATED MARKETS

• 16.1 INTRODUCTION
• 16.2 LIMITATIONS
  • 16.2.1 INFUSION PUMPS MARKET
    • 16.2.1.1 Market definition
    • 16.2.1.2 Infusion pumps market, by product
    • 16.2.1.3 Infusion pumps market, by application
    • 16.2.1.4 Infusion pumps market, by setting
    • 16.2.1.5 Infusion pumps market, by region

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS

List of Tables

• TABLE 1 ELASTOMERIC INFUSION PUMPS MARKET: IMPACT OF PORTER'S FIVE FORCES
• TABLE 2 GLOBAL GDP GROWTH PROJECTION, BY REGION, 2021-2028 (USD TRILLION)
• TABLE 3 ELASTOMERIC INFUSION PUMPS MARKET: ROLES OF COMPANIES IN ECOSYSTEM
• TABLE 4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD/UNIT)
• TABLE 5 AVERAGE SELLING PRICE TREND OF ELASTOMERIC INFUSION PUMPS, BY REGION, 2023-2030 (USD/UNIT)
• TABLE 6 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
• TABLE 7 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
• TABLE 8 ELASTOMERIC INFUSION PUMPS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2025-2026
• TABLE 9 ELASTOMERIC INFUSION PUMPS MARKET: LIST OF KEY PATENTS, 2022-2024
• TABLE 10 TOP USE CASES AND MARKET POTENTIAL
• TABLE 11 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
• TABLE 12 ELASTOMERIC INFUSION PUMPS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
• TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
• TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
• TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
• TABLE 16 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
• TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
• TABLE 18 GLOBAL INDUSTRY STANDARDS IN ELASTOMERIC INFUSION PUMPS MARKET
• TABLE 19 CERTIFICATIONS, LABELING, ECO-STANDARDS IN ELASTOMERIC INFUSION PUMPS MARKET
• TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY (%)
• TABLE 21 KEY BUYING CRITERIA, BY END-USE INDUSTRY
• TABLE 22 UNMET NEEDS IN ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY
• TABLE 23 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 24 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 25 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 26 ELASTOMERIC INFUSION PUMPS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 27 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 28 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 29 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 30 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 31 US: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 32 US: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 33 US: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 34 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 35 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 36 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 37 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 38 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 39 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 40 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 41 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 42 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 43 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 44 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 45 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 46 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 47 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 48 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 49 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 50 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 51 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 52 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 53 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 54 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 55 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 56 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 57 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 58 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 59 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 60 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 61 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 62 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 63 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 64 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 65 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 66 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 67 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 68 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 69 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 70 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 71 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 72 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 73 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 74 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 75 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 76 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 77 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 78 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 79 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 80 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 81 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 82 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 83 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 84 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 85 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 86 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 87 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 88 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 89 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 90 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 91 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 92 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 93 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 94 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 95 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 96 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 97 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 98 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 99 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 100 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 101 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 102 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 103 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 104 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 105 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 106 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 107 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 108 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 109 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 110 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 111 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 112 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 113 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 114 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 115 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 116 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 117 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 118 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
• TABLE 119 ELASTOMERIC INFUSION PUMPS MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2020-OCTOBER 2025
• TABLE 120 ELASTOMERIC INFUSION PUMPS MARKET: DEGREE OF COMPETITION, 2024
• TABLE 121 ELASTOMERIC INFUSION PUMPS MARKET: REGIONAL FOOTPRINT, 2024
• TABLE 122 ELASTOMERIC INFUSION PUMPS MARKET: TYPE FOOTPRINT, 2024
• TABLE 123 ELASTOMERIC INFUSION PUMPS MARKET: APPLICATION FOOTPRINT, 2024
• TABLE 124 ELASTOMERIC INFUSION PUMPS MARKET: END-USE INDUSTRY FOOTPRINT, 2024
• TABLE 125 ELASTOMERIC INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
• TABLE 126 ELASTOMERIC INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
• TABLE 127 ELASTOMERIC INFUSION PUMPS MARKET: DEALS, JANUARY 2020-OCTOBER 2025
• TABLE 128 ELASTOMERIC INFUSION PUMPS MARKET: EXPANSIONS, JANUARY 2020-OCTOBER 2025
• TABLE 129 BAXTER: COMPANY OVERVIEW
• TABLE 130 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 131 B. BRAUN SE: COMPANY OVERVIEW
• TABLE 132 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 133 B. BRAUN SE: DEALS
• TABLE 134 NIPRO: COMPANY OVERVIEW
• TABLE 135 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 136 NIPRO: DEALS
• TABLE 137 NIPRO: EXPANSIONS
• TABLE 138 AVNS: COMPANY OVERVIEW
• TABLE 139 AVNS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 140 VYGON: COMPANY OVERVIEW
• TABLE 141 VYGON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 142 VYGON: DEALS
• TABLE 143 VYGON: EXPANSIONS
• TABLE 144 WOOYOUNG MEDICAL CO., LTD.: COMPANY OVERVIEW
• TABLE 145 WOOYOUNG MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 146 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
• TABLE 147 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
• TABLE 148 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: DEALS
• TABLE 149 AMBU A/S: COMPANY OVERVIEW
• TABLE 150 AMBU A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 151 AMBU A/S: EXPANSIONS
• TABLE 152 PALEX: COMPANY OVERVIEW
• TABLE 153 PALEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 154 PALEX: DEALS
• TABLE 155 DAIKEN MEDICAL CO., LTD.: COMPANY OVERVIEW
• TABLE 156 DAIKEN MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 157 PROMECON GMBH: COMPANY OVERVIEW
• TABLE 158 S&S MED: COMPANY OVERVIEW
• TABLE 159 EPIC MEDICAL: COMPANY OVERVIEW
• TABLE 160 MULTIMEDICAL S.R.L.: COMPANY OVERVIEW
• TABLE 161 TECNOLINE S.P.A.: COMPANY OVERVIEW
• TABLE 162 ZHEJIANG FERT MEDICAL DEVICE CO., LTD.: COMPANY OVERVIEW
• TABLE 163 ACE MEDICAL: COMPANY OVERVIEW
• TABLE 164 GAMASTECH SRL: COMPANY OVERVIEW
• TABLE 165 FIRST MEDICAL SOURCE: COMPANY OVERVIEW
• TABLE 166 DELTAMED: COMPANY OVERVIEW
• TABLE 167 VIKYMED ITALIA SRL: COMPANY OVERVIEW
• TABLE 168 CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
• TABLE 169 MAIS INDIA: COMPANY OVERVIEW
• TABLE 170 NARANG MEDICAL LIMITED: COMPANY OVERVIEW
• TABLE 171 ZEBRA MEDICAL: COMPANY OVERVIEW
• TABLE 172 INFUSION PUMPS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
• TABLE 173 INFUSION PUMPS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
• TABLE 174 INFUSION PUMPS MARKET, BY SETTING, 2020-2027 (USD MILLION)
• TABLE 175 INFUSION PUMPS MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

• FIGURE 1 ELASTOMERIC INFUSION PUMPS MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
• FIGURE 3 GLOBAL ELASTOMERIC INFUSION PUMPS MARKET, 2023-2030
• FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ELASTOMERIC INFUSION PUMPS MARKET (2020-2025)
• FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF ELASTOMERIC INFUSION PUMPS MARKET DURING FORECAST PERIOD
• FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN ELASTOMERIC INFUSION PUMPS MARKET, 2024
• FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 8 HIGH DEMAND IN HOSPITALS AND HOMECARE SETTINGS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
• FIGURE 9 US DOMINATED ELASTOMERIC INFUSION PUMPS MARKET IN NORTH AMERICA
• FIGURE 10 CONTINUOUS RATE SEGMENT DOMINATED ELASTOMERIC INFUSION PUMPS MARKET IN 2024
• FIGURE 11 PAIN MANAGEMENT SEGMENT ACCOUNTED FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2024
• FIGURE 12 HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2024
• FIGURE 13 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 14 ELASTOMERIC INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 15 US CANCER SURVIVORS (MALE & FEMALE) BY YEARS SINCE DIAGNOSIS, AS OF JANUARY 2025
• FIGURE 16 ELASTOMERIC INFUSION PUMPS MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 17 ELASTOMERIC INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS
• FIGURE 18 ELASTOMERIC INFUSION PUMPS MARKET: ECOSYSTEM ANALYSIS
• FIGURE 19 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024
• FIGURE 20 AVERAGE SELLING PRICE TREND OF ELASTOMERIC INFUSION PUMPS, BY REGION, 2023-2030
• FIGURE 21 EXPORT SCENARIO FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
• FIGURE 22 IMPORT SCENARIO FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
• FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• FIGURE 24 INVESTMENT AND FUNDING SCENARIO, 2018-2024
• FIGURE 25 LIST OF MAJOR PATENTS FOR ELASTOMERIC INFUSION PUMPS, 2015-2024
• FIGURE 26 MAJOR PATENTS APPLIED AND GRANTED RELATED TO ELASTOMERIC INFUSION PUMPS, BY COUNTRY/REGION, 2015-2024
• FIGURE 27 ELASTOMERIC INFUSION PUMPS MARKET DECISION-MAKING FACTORS
• FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY
• FIGURE 29 KEY BUYING CRITERIA, BY END-USE INDUSTRY
• FIGURE 30 ADOPTION BARRIERS & INTERNAL CHALLENGES
• FIGURE 31 CONTINUOUS RATE SEGMENT TO DOMINATE ELASTOMERIC INFUSION PUMPS MARKET DURING FORECAST PERIOD
• FIGURE 32 PAIN MANAGEMENT TO ACCOUNT FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2025
• FIGURE 33 HOSPITALS TO BE LARGEST END-USE INDUSTRY OF ELASTOMERIC INFUSION PUMPS IN 2025
• FIGURE 34 CHINA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
• FIGURE 35 NORTH AMERICA TO ACCOUNT FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2025
• FIGURE 36 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET SNAPSHOT
• FIGURE 37 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET SNAPSHOT
• FIGURE 38 ELASTOMERIC INFUSION PUMPS: MARKET SHARE ANALYSIS, 2024
• FIGURE 39 ELASTOMERIC INFUSION PUMPS MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2020-2024
• FIGURE 40 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY VALUATION, 2024
• FIGURE 41 ELASTOMERIC INFUSION PUMPS MARKET: FINANCIAL MATRIX: EV/ EBITDA RATIO, 2024
• FIGURE 42 ELASTOMERIC INFUSION PUMPS MARKET: YEAR-TO-DATE PRICE AND FIVE-YEAR STOCK BETA, 2024
• FIGURE 43 ELASTOMERIC INFUSION PUMPS MARKET: PRODUCT/BRAND COMPARISON
• FIGURE 44 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 45 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY FOOTPRINT, 2024
• FIGURE 46 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 47 BAXTER: COMPANY SNAPSHOT
• FIGURE 48 B. BRAUN SE: COMPANY SNAPSHOT
• FIGURE 49 NIPRO: COMPANY SNAPSHOT
• FIGURE 50 AVNS: COMPANY SNAPSHOT
• FIGURE 51 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: COMPANY SNAPSHOT
• FIGURE 52 AMBU A/S: COMPANY SNAPSHOT
• FIGURE 53 DAIKEN MEDICAL CO., LTD.: COMPANY SNAPSHOT
• FIGURE 54 ELASTOMERIC INFUSION PUMPS MARKET: RESEARCH DESIGN
• FIGURE 55 BREAKDOWN OF INTERVIEWS WITH EXPERTS
• FIGURE 56 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
• FIGURE 57 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
• FIGURE 58 ELASTOMERIC INFUSION PUMPS MARKET: APPROACH 1
• FIGURE 59 ELASTOMERIC INFUSION PUMPS MARKET: APPROACH 2
• FIGURE 60 ELASTOMERIC INFUSION PUMPS MARKET: DATA TRIANGULATION